| scholarly article | Q13442814 |
| P50 | author | Anuradha Ganesan | Q86008693 |
| Amy C Weintrob | Q109303160 | ||
| Vincent C Marconi | Q41553111 | ||
| Lynn E. Eberly | Q42429872 | ||
| Brian K. Agan | Q55128190 | ||
| Nancy F Crum-Cianflone | Q58066164 | ||
| P2093 | author name string | Susan Fraser | |
| Mollie Poehlman Roediger | |||
| R Vincent Barthel | |||
| Maryam Headd | |||
| P2860 | cites work | When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort | Q73523868 |
| Central obesity and dietary intake in HIV/AIDS patients | Q79298279 | ||
| CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study | Q81436601 | ||
| National Medical Spending Attributable To Overweight And Obesity: How Much, And Who's Paying? | Q22241403 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Guidelines for healthy weight | Q33702693 | ||
| Disorders of glucose metabolism in patients infected with human immunodeficiency virus | Q34092346 | ||
| Years of life lost due to obesity | Q34169086 | ||
| Nutrition in the era of highly active antiretroviral therapy | Q34255660 | ||
| Excess deaths associated with underweight, overweight, and obesity | Q34412581 | ||
| Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | Q34567572 | ||
| Beyond body mass index | Q34742832 | ||
| Obesity among patients with HIV: the latest epidemic | Q37255171 | ||
| Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. | Q38472417 | ||
| Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. | Q38499346 | ||
| HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. | Q39730072 | ||
| Obesity in HIV-infection: dietary correlates | Q40292534 | ||
| Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy. | Q43538922 | ||
| Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy | Q44406903 | ||
| Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study | Q44486385 | ||
| Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 | ||
| Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial | Q44975155 | ||
| Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. | Q45731576 | ||
| Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy | Q45740350 | ||
| A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. | Q46618919 | ||
| State-specific prevalence of obesity among adults--United States, 2005. | Q46628995 | ||
| Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy | Q47176094 | ||
| Weight and body composition in a cohort of HIV-positive men and women. | Q47207979 | ||
| Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. | Q47289119 | ||
| Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. | Q47345030 | ||
| Changes in weight and lean body mass during highly active antiretroviral therapy | Q47403936 | ||
| Increase in body cell mass and decrease in wasting are associated with increasing potency of antiretroviral therapy for HIV infection. | Q51975157 | ||
| Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | Q54656315 | ||
| The Walter Reed staging classification for HTLV-III/LAV infection. | Q55244405 | ||
| Increasing Trends in Incidence of Overweight and Obesity over 5 Decades | Q57308711 | ||
| Wasting and obesity in HIV outpatients | Q58463582 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| obesity | Q12174 | ||
| epidemic | Q44512 | ||
| P304 | page(s) | e10106 | |
| P577 | publication date | 2010-04-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Increasing rates of obesity among HIV-infected persons during the HIV epidemic | |
| P478 | volume | 5 |
| Q36044780 | 'If you have a problem with your heart, you have a problem with your life': Self-perception and behaviour in relation to the risk of ischaemic heart disease in people living with HIV. |
| Q35881469 | A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings |
| Q64240956 | A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? |
| Q35827873 | A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus |
| Q37972113 | Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy |
| Q52720640 | Adipocytes impair efficacy of antiretroviral therapy. |
| Q37187518 | Adipose tissue and immune function: a review of evidence relevant to HIV infection |
| Q30244921 | Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions |
| Q33981433 | Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV. |
| Q91711355 | Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity |
| Q37467991 | Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection |
| Q38562427 | Bariatric surgery: An HIV-positive patient's successful journey |
| Q36021419 | Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010 |
| Q34718097 | Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy |
| Q90261479 | Body mass index variation over time and associated factors among HIV-positive adults on second-line ART in north-west Ethiopia: a retrospective follow-up study |
| Q36758512 | Body mass index, depression and sexual transmission risk behaviors among HIV-positive MSM. |
| Q37600877 | Body mass index, depression, and condom use among HIV-infected men who have sex with men: a longitudinal moderation analysis |
| Q37520967 | Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons |
| Q34716740 | Brain morphometric correlates of metabolic variables in HIV: the CHARTER study |
| Q34849237 | Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study |
| Q34674774 | Changes in metabolic syndrome status after initiation of antiretroviral therapy |
| Q37433073 | Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women |
| Q64112088 | Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people |
| Q38769192 | Comprehensive and Medically Appropriate Food Support Is Associated with Improved HIV and Diabetes Health |
| Q35578711 | Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. |
| Q40116616 | Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults |
| Q35102751 | Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study |
| Q33711577 | Dietary intake and body composition in HIV-positive and -negative South African women |
| Q38963668 | Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? |
| Q40710920 | Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana |
| Q35990560 | FUNCTIONAL LIMITATIONS AND ADIPOKINES IN HIV-INFECTED OLDER ADULTS. |
| Q36654972 | Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection |
| Q54457694 | Feasibility of Bariatric Surgery in the HIV-Infected Patients. |
| Q90436693 | Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa |
| Q38659387 | HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer |
| Q94601031 | HIV infection, and overweight and hypertension: a cross-sectional study of HIV-infected adults in Western Kenya |
| Q33896762 | HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problems |
| Q52613761 | HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy. |
| Q36621913 | High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial |
| Q37642702 | High risk of obesity and weight gain for HIV-infected uninsured minorities |
| Q38741619 | Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV. |
| Q39820692 | Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment |
| Q33968354 | Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya |
| Q44013632 | Hypertension is common among HIV-infected persons, but not associated with HAART. |
| Q47550326 | Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection. |
| Q34034101 | Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection |
| Q34205448 | Impact of randomized antiretroviral therapy initiation on glucose metabolism |
| Q88029274 | Incidence and Risk Factors for Overweight and Obesity after Initiation of Antiretroviral Therapy in Dar es Salaam, Tanzania |
| Q34502149 | Increasing Obesity in Treated Female HIV Patients from Sub-Saharan Africa: Potential Causes and Possible Targets for Intervention |
| Q37003062 | Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults |
| Q43830146 | Longitudinal association between BMI at diagnosis and HIV disease progression |
| Q37899071 | Management of fat accumulation in patients with HIV infection |
| Q38175873 | Metabolic consequences of HIV: pathogenic insights. |
| Q36346699 | Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals |
| Q59798114 | Metabolically Healthy or Metabolically Unhealthy Obese HIV-Infected Patients: Mostly a Matter of Age? |
| Q36444419 | Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV disease |
| Q39238714 | Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. |
| Q30979829 | Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey |
| Q34802246 | Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study |
| Q89771713 | Obesity and Weight Gain in Persons with HIV |
| Q88555253 | Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors |
| Q94570788 | Overweight and Obesity among Recipients of Antiretroviral Therapy at HIV Clinics in Gaborone, Botswana: Factors Associated with Change in Body Mass Index |
| Q58073610 | Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective |
| Q43284792 | Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania |
| Q95817406 | Reducing Undernutrition through Counseling on Diversified Food Intake among Adult People Living with HIV on HAART, Northern Ethiopia |
| Q36406918 | Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada |
| Q55256139 | Risk factors associated with overweight and obesity in HIV-infected people: Aging, behavioral factors but not cART in a cross-sectional study. |
| Q35979650 | Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy |
| Q38691562 | Severe food insecurity is associated with overweight and increased body fat among people living with HIV in the Dominican Republic. |
| Q36634864 | Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons |
| Q90016280 | Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy |
| Q54204816 | Sleeve Gastrectomy in Morbidly Obese HIV Patients: Focus on Anti-retroviral Treatment Absorption After Surgery. |
| Q89688886 | T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV |
| Q38194964 | Tenofovir, emtricitabine, and darunavir/ritonavir pharmacokinetics in an HIV-infected patient after Roux-en-Y gastric bypass surgery |
| Q37045052 | The Distribution of Obesity Phenotypes in HIV-Infected African Population. |
| Q59806829 | The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality |
| Q35557264 | The effect of aging, nutrition, and exercise during HIV infection |
| Q36436780 | The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy |
| Q37662407 | The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States |
| Q60046592 | Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats |
| Q35012544 | Undernutrition among HIV positive women in Humera hospital, Tigray, Ethiopia, 2013: antiretroviral therapy alone is not enough, cross sectional study |
| Q90673145 | Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials |
| Q39772256 | Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals. |
| Q40076712 | Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens |
| Q35974655 | Weight change after antiretroviral therapy and mortality |
| Q37496832 | Weight status and associated factors among HIV infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa |
Search more.